Dosage and injection frequency don't typically change the deferral decision, but stability on the medication and absence of recent adverse events may factor into individual cases
You may not be a good candidate if: You have a history of pancreatitis or currently have gallbladder disease with active gallstones Youre pregnant or planning to become pregnant You have a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) or multiple endocrine neoplasia syndrome type 2 (a disease that increases the risk of certain types of tumors) You have severe kidney disease Youre allergic to any of the ingredients in the medication This list isnt exhaustive, and other health conditions may also influence whether weight loss injections are suitable for you
Accessed Apr
36 In a series of double-blind, placebo-controlled RCTs (ALADIN I, II, and III), ALA 600 mg/d administered both orally and IV was found to be safe with no significant difference in adverse reactions between treatment and placebo groups
In fiscal year 2024, GLP-1s cost Connecticuts Medicaid program $85 million, after factoring in rebates, which amounted to 35% of the entire Medicaid pharmaceutical budget for the year
its standard practice in any serious lab for a few good reasons: It Preserves the Master Stock: You only ever thaw the exact amount you need for a single experiment